Remote Patient Monitoring Enters a New Era

article image

Interest in remote patient monitoring is intensifying in the wake of the COVID-19 pandemic, as more healthcare shifts to home-based settings. This is the first in a series of articles on the future of RPM and how both established competitors and innovative start-ups are working to meet growing demand for remote care technologies. First up: a discussion with James Mault, MD, co-founder and CEO of BioIntelliSense.

Telemedicine and remote patient monitoring (RPM) have been pushed to the forefront during the COVID-19 health emergency and companies that operate in this field are experiencing unprecedented growth and demand for their products and services. As the pandemic accelerates the ongoing move toward digital health, a variety of remote care options will be needed to meet future demand. That opens the door not only for existing RPM competitors but also for a growing number of consumer tech companies and medtech start-ups seeking to make an impact in the remote healthcare marketplace with technologies ranging from fitness wearables to implantable sensors.


This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Sign up for All-Access

Join our global community with a subscription to both MedTech Strategist and Market Pathways for one low price.



We're here to help! Please contact us at: